a public good project by the
Synthesis
Company
of California

© 2026

Relation between plasma concentration and clinical efficacy after sublingual single dose apomorphine in Parkinson's disease | doi.page

0 citations0 references

Google Scholar doi.org

Relation between plasma concentration and clinical efficacy after sublingual single dose apomorphine in Parkinson's disease

European Journal of Clinical Pharmacology·1991·Vol. 41(5), pp. 493–494

Citations Over Time

Franck Durif, E. Jeanneau, F Serre-Debeauvais, Didier Deffond, Alain Eschalier, M Tournilhac

Related Papers

→ Continuous Dopaminergic Stimulation in Parkinson's Disease(1987)27 cited
→ Apomorphine Infusion and the Long-Duration Response to Levodopa in Advanced Parkinson's Disease(2003)14 cited
→ P2.093 Switch from subcutaneous apomorphine to intraduodenal levodopa offers additional beneflt on motor fluctuations and dyskinesias in advanced Parkinson's disease(2009)
Apomorphine subcutaneous infusion, duodenal infusion of levodopa and deep brain stimulation – three advanced treatment options for the advanced Parkinson’s disease(2016)
→ Faculty Opinions recommendation of EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.(2019)